KLISBio Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
KLISBio General Information
Description
Developer of an innovative medical technology designed to find new ways for tissue regeneration. The company's technology offers silk-based bio-materials that help to regenerate human tissues, including those present in the vascular system, and then to degrade and be safely absorbed in the body, enabling medical research companies to avail premium products harnessing the power of nano-fibers and use them for the treatment of tissue-related diseases.
Contact Information
Website
www.klis.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
- Via Cavour 2
- 22074 Lomazzo(Como)
- Italy
KLISBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 00.000 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 21-Apr-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 4. Seed Round | 11-Dec-2015 | 00000 | 00000 | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Grant | 05-Aug-2015 | $55K | Completed | Generating Revenue | ||
| 1. Grant | 05-Dec-2014 | $31.1K | Completed | Startup |
KLISBio Patents
KLISBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018248085-A1 | Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers | Pending | 04-Apr-2017 | 000000000 | |
| CA-3058866-A1 | Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers | Pending | 04-Apr-2017 | 000000000 | |
| EP-3607117-A1 | Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers | Pending | 04-Apr-2017 | 000000000 | |
| US-20200109491-A1 | Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers | Pending | 04-Apr-2017 | 000000000 | 0 |
| US-20170312387-A1 | Process for the production of a hybrid structure consisting of coupled silk fibroin microfibers and nanofibers, hybrid structure thus obtained and its use as implantable medical device | Active | 27-Oct-2014 | A61L27/227 | 0 |
KLISBio Executive Team (6)
KLISBio Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Antonio Alessandrino Ph.D | KLISBio | Co-Founder, Chief Technology Officer & Board Member | 000 0000 |
| Gabriele Grecchi | KLISBio | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Rodrigo Bianchi | KLISBio | President & Chairman | 000 0000 |
KLISBio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
KLISBio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Xyence | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 | ||
| PNICube | Corporation | 000 0000 | 000000 0 | ||
| Anya Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| ComoNext | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |